<DOC>
	<DOCNO>NCT02217475</DOCNO>
	<brief_summary>The purpose study determine whether Cenicriviroc effective safe treatment nonalcoholic steatohepatitis ( NASH ) adult subject liver fibrosis .</brief_summary>
	<brief_title>Efficacy Safety Study Cenicriviroc Treatment NASH Adult Subjects With Liver Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>TAK-652</mesh_term>
	<criteria>Adult subject age 1875 Histological evidence NASH , base biopsy , NAS &gt; = 4 least 1 component NAS Histological evidence liver fibrosis define NASH CRN System Stage 1 3 Meeting 3 major criterion ( , b , c ) : 1 . Documented evidence type 2 diabetes mellitus 2 . High body mass index ( &gt; 25 kg/m2 ) least one follow criterion metabolic syndrome , define National Cholesterol Education Program : Central obesity : waist circumference ≥ 102 cm 40 inch ( male ) , ≥ 88 cm 35 inch ( female ) Dyslipidemia : Triglycerides ≥ 1.7 mmol/L ( 150 mg/dL ) Dyslipidemia : Highdensity lipoprotein ( HDL ) cholesterol &lt; 40 mg/dL ( male ) , &lt; 50 mg/dL ( female ) Blood pressure ≥ 130/85 mmHg ( currently treat hypertension ) Fasting plasma glucose ≥ 6.1 mmol/L ( 110 mg/dL ) 3 . Bridging fibrosis ( NASH CRN Stage 3 ) and/or definite NASH ( NAS ≥ 5 ) Agree one liver biopsy Screening , one Year 1 , one end study treatment ( Year 2 ) AST ALT ≤ 5 × upper limit normal ( ULN ) Hepatitis B surface Antigen ( HBsAg ) positive Hepatitis C antibody ( HCVAb ) positive follow 2 exception : 1 . Subjects previously treat viral hepatitis C least 1year period since document sustain virologic response Week 12 ( posttreatment ) may eligible eligibility criterion meet 2 . Subjects presence hepatitis C antibody negative hepatitis C virus RNA without treatment ( i.e. , spontaneous clearance ) may eligible eligibility criterion meet Prior plan liver transplantation Other know cause chronic liver disease , include alcoholic liver disease History cirrhosis and/or hepatic decompensation include ascites , hepatic encephalopathy variceal bleed Alcohol consumption great 21 units/week male 14 units/week female ( one unit alcohol ½ pint beer [ 285 mL ] , 1 glass spirit [ 25 mL ] 1 glass wine [ 125 mL ] ) HIV1 HIV2 infection Weight reduction bariatric surgery past 5 year plan conduct study ( include gastric banding ) Females pregnant breastfeed Any clinically significant disorder prior therapy , opinion investigator , would make subject unsuitable study unable comply dose protocol requirement .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
</DOC>